WallStreetZenWallStreetZen

NASDAQ: HLVX
Hillevax Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for HLVX

Based on 4 analysts offering 12 month price targets for Hillevax Inc.
Min Forecast
$24.00+38.97%
Avg Forecast
$32.00+85.29%
Max Forecast
$40.00+131.62%

Should I buy or sell HLVX stock?

Based on 4 analysts offering ratings for Hillevax Inc.
Strong Buy
Strong Buy
3 analysts 75%
Buy
1 analysts 25%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their HLVX stock forecasts and price targets.

HLVX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Guggenheim
Bottom 16%
16
Strong BuyInitiates Coverage On$40.00+131.62%2022-05-24
SVB Leerink
Top 9%
92
BuyInitiates Coverage On$30.00+73.71%2022-05-24
JP Morgan
Bottom 6%
6
Strong BuyInitiates Coverage On$24.00+38.97%2022-05-24
Stifel Nicolaus
Bottom 7%
7
Strong BuyInitiates Coverage On$34.00+96.87%2022-05-24

1 of 1

Forecast return on equity

Is HLVX forecast to generate an efficient return?
Company
N/A
Industry
-0.01%
Market
13.24%

Forecast return on assets

Is HLVX forecast to generate an efficient return on assets?
Company
N/A
Industry
0.12%

HLVX earnings per share forecast

What is HLVX's earnings per share in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
-$5.48
Avg 2 year Forecast
-$4.69
Avg 3 year Forecast
-$4.16

HLVX revenue forecast

What is HLVX's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$12.5M
Avg 2 year Forecast
$116.2M
Avg 3 year Forecast
$528.4M

HLVX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
HLVX$17.27$32.00+85.29%Strong Buy
SGMO$3.51$13.00+270.37%Strong Buy
CERS$3.25$9.67+197.42%Strong Buy
TNGX$6.54$10.00+52.91%Buy
ARDX$3.08$6.67+116.46%Strong Buy
View Top Biotech Stocks

Hillevax Stock Forecast FAQ

Is Hillevax Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: HLVX) stock is to Strong Buy HLVX stock.

Out of 4 analysts, 3 (75%) are recommending HLVX as a Strong Buy, 1 (25%) are recommending HLVX as a Buy, 0 (0%) are recommending HLVX as a Hold, 0 (0%) are recommending HLVX as a Sell, and 0 (0%) are recommending HLVX as a Strong Sell.

If you're new to stock investing, here's how to buy Hillevax stock.

What is HLVX's earnings growth forecast for 2023-2025?

(NASDAQ: HLVX) Hillevax's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.4%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 21.99%.

Hillevax's earnings in 2023 is N/A.On average, 3 Wall Street analysts forecast HLVX's earnings for 2023 to be -$182,732,025, with the lowest HLVX earnings forecast at -$242,420,040, and the highest HLVX earnings forecast at -$117,041,863. On average, 3 Wall Street analysts forecast HLVX's earnings for 2024 to be -$156,389,269, with the lowest HLVX earnings forecast at -$193,735,961, and the highest HLVX earnings forecast at -$128,379,251.

In 2025, HLVX is forecast to generate -$138,716,282 in earnings, with the lowest earnings forecast at -$148,052,954 and the highest earnings forecast at -$129,713,061.

What is HLVX's revenue growth forecast for 2026-2028?

(NASDAQ: HLVX) Hillevax's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.5%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.21%.

Hillevax's revenue in 2023 is N/A.On average, 1 Wall Street analysts forecast HLVX's revenue for 2026 to be $416,815,750, with the lowest HLVX revenue forecast at $416,815,750, and the highest HLVX revenue forecast at $416,815,750. On average, 2 Wall Street analysts forecast HLVX's revenue for 2027 to be $3,876,053,022, with the lowest HLVX revenue forecast at $1,467,191,440, and the highest HLVX revenue forecast at $6,284,914,605.

In 2028, HLVX is forecast to generate $17,619,635,384 in revenue, with the lowest revenue forecast at $17,619,635,384 and the highest revenue forecast at $17,619,635,384.

What is HLVX's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: HLVX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.12%.

What is HLVX's Price Target?

According to 4 Wall Street analysts that have issued a 1 year HLVX price target, the average HLVX price target is $32.00, with the highest HLVX stock price forecast at $40.00 and the lowest HLVX stock price forecast at $24.00.

On average, Wall Street analysts predict that Hillevax's share price could reach $32.00 by May 24, 2023. The average Hillevax stock price prediction forecasts a potential upside of 85.29% from the current HLVX share price of $17.27.

What is HLVX's Earnings Per Share (EPS) forecast for 2023-2025?

(NASDAQ: HLVX) Hillevax's current Earnings Per Share (EPS) is N/A. On average, analysts forecast that HLVX's EPS will be -$5.48 for 2023, with the lowest EPS forecast at -$7.27, and the highest EPS forecast at -$3.51. On average, analysts forecast that HLVX's EPS will be -$4.69 for 2024, with the lowest EPS forecast at -$5.81, and the highest EPS forecast at -$3.85. In 2025, HLVX's EPS is forecast to hit -$4.16 (min: -$4.44, max: -$3.89).

What is HLVX's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: HLVX) forecast ROE is N/A, which is considered weak.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.